FDA inspection
DIAGAST: FDA inspection ending Apr 19, 2024
FDA inspection 1236304 · Voluntary Action Indicated (VAI) · Loos
Key facts
| Inspection ID | 1236304 |
|---|---|
| Firm | DIAGAST |
| FEI number | 3006261638 |
| Address | Parc Eurasante, 251 Avenue Eugene Avinee |
| City | Loos |
| Fiscal year | 2024 |
| Inspection end date | Apr 19, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data